Item 7.01 Regulation FD Disclosure.
On January 10, 2022, Mirati Therapeutics, Inc. (the “Company”) will present a
corporate presentation at the J.P. Morgan 40th Annual Healthcare Conference. A
copy of the corporate presentation is attached hereto as Exhibit 99.1 to this
Current Report on Form 8-K.
The information set forth in this Item 7.01 and in the corporate presentation
attached hereto as Exhibit 99.1, is deemed to be “furnished” and shall not be
deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), or otherwise subject to the
liabilities of that Section. The information set forth in this Item 7.01,
including Exhibit 99.1, shall not be deemed incorporated by reference into any
filing under the Exchange Act or the Securities Act of 1933, as amended, except
to the extent that the Company specifically incorporates it by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1 Corporate Presentation. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source Glimpses